ADC Technology

Sorrento Therapeutics Announced a Definitive Agreement to Acquire Concortis Biosystems
Nov 18, 2013
Sorrento Therapeutics, a clinical-stage biopharmaceutical company, has announced a definitive agreement to acquire US-based Concortis Biosystems. This acquisition provides Sorrento Therapeutics with a comprehensive technology platform for ...

Tags: Concortis Biosystems, Sorrento Therapeutics
Develops Novel Anticancer Therapeutics Has Signed a Licensing Agreement with Novartis
Oct 15, 2013
US-based biotechnology firm that develops novel anticancer therapeutics using antibody-drug conjugate (ADC) technology, ImmunoGen (IMGN) has signed a licensing agreement with Novartis, pursuant to which, Novartis has the exclusive right to ...

Tags: Immunogen, Novartis, ADC Technology
Ambrx and China-Based Zhejiang Medicine Collaborated to Develop and Commercialize ARX788
Jun 21, 2013
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...

Tags: Ambrx, Medicine